or
forgot password

    • cancer clinical trials in cullman, AL

    • An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    North Central Neurology Associates, P.C.
    Cullman, Alabama
    Multiple Sclerosis, Relapsing-Remitting
    Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
    Cullman Oncology and Hematology
    Cullman, Alabama 35058
    Pain, Cancer
    Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
    North Central Neurology Associates, PC, 1809 Kress Street
    Cullman, Alabama 35058
    Multiple Sclerosis
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One
    North Central Neurology Associates, P.C.
    Cullman, Alabama
    Multiple Sclerosis, Relapsing-Remitting
    Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two
    North Central Neurology Associates, P.C.
    Cullman, Alabama
    Multiple Sclerosis, Relapsing-Remitting
    Long Term Study of Fingolimod in MS Patients From the FTY Clinical Program
    North Central Neurology Associates, PC
    Cullman, Alabama 35058
    Multiple Sclerosis